About Venus Remedies Ltd
Venus Remedies a research-driven global pharmaceutical company specializing in critical care, antimicrobial resistance (AMR), and oncology
Founded
1989
CEO
Pawan Chaudhary
Employees
1,298
HQ
Panchkula, India
Finished Products
1Sale of Products
₹1,203.01Cr2Other Operating Revenue
₹10.60Cr3Income from Research Activites
₹1.07CrRaw Materials
1Cost of material Consumed
₹692.97Cr2Purchase of Stock in Trade
₹25.04Cr3Others
₹13.07CrAbout Venus Remedies Ltd
Venus Remedies a research-driven global pharmaceutical company specializing in critical care, antimicrobial resistance (AMR), and oncology
Founded:1989
CEO:Pawan Chaudhary
Employees:1,298
HQ:Panchkula, India
Finished Products
1Sale of Products
₹1,203.01Cr2Other Operating Revenue
₹10.60Cr3Income from Research Activites
₹1.07CrRaw Materials
1Cost of material Consumed
₹692.97Cr2Purchase of Stock in Trade
₹25.04Cr3Others
₹13.07CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹2,044
52W Low
₹424
Volume25.25K
Avg VolumeN/A
Beta0.87
Dividend Yield0.61%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
18.74x
Valuation
P/B Ratio
3.28x
Valuation
EPS
₹86.92
Valuation
Dividend Yield
0.61%
Valuation
ROE
15.49%
Profitability
ROCE
19.85%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical FormulationRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.02x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.3%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.